首页> 外文期刊>Analytical and Bioanalytical Chemistry >Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry
【24h】

Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry

机译:液相色谱串联质谱法同时分析汗液中丁丙诺啡,美沙酮,可卡因,鸦片和尼古丁代谢物

获取原文
获取原文并翻译 | 示例
           

摘要

A liquid chromatography tandem mass spectrometry method for buprenorphine (BUP), norbuprenorphine (NBUP), methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), cocaine, benzoylecgonine, ecgonine methyl ester (EME), morphine, codeine, 6-acetylmorphine, heroin, 6-acetylcodeine, cotinine, and trans-3′-hydroxycotinine quantification in sweat was developed and comprehensively validated. Sweat patches were mixed with 6 mL acetate buffer at pH 4.5, and supernatant extracted with Strata-XC-cartridges. Reverse-phase separation was achieved with a gradient mobile phase of 0.1% formic acid and acetonitrile in 15 min. Quantification was achieved by multiple reaction monitoring of two transitions per compound. The assay was a linear 1–1,000 ng/patch, except EME 5–1,000 ng/patch. Intra-, inter-day and total imprecision were <10.1%CV, analytical recovery 87.2–107.7%, extraction efficiency 35.3–160.9%, and process efficiency 25.5–91.7%. Ion suppression was detected for EME (−63.3%) and EDDP (−60.4%), and enhancement for NBUP (42.6%). Deuterated internal standards compensated for these effects. No carryover was detected, and all analytes were stable for 24 h at 22 °C, 72 h at 4 °C, and after three freeze/thaw cycles. The method was applied to weekly sweat patches from an opioid-dependent BUP-maintained pregnant woman; 75.0% of sweat patches were positive for BUP, 93.8% for cocaine, 37.5% for opiates, 6.3% for methadone and all for tobacco biomarkers. This method permits a fast and simultaneous quantification of 14 drugs and metabolites in sweat patches, with good selectivity and sensitivity.
机译:液相色谱串联质谱法用于丁丙诺啡(BUP),去甲丁丙诺啡(NBUP),美沙酮,2-亚乙基-1,5-二甲基-3,3-二苯基吡咯烷(EDDP),可卡因,苯甲酰基芽子碱,芽子碱甲酯(EME),汗液中吗啡,可待因,6-乙酰吗啡,海洛因,6-乙酰可待因,可替宁和反式3'-羟基可卡因的定量方法得到了开发和全面验证。将出汗斑块与6 mL pH 4.5的醋酸盐缓冲液混合,并用Strata-XC-Cartridges提取上清液。在15分钟内使用0.1%甲酸和乙腈的梯度流动相实现了反相分离。通过对每个化合物的两个过渡进行多反应监测来实现定量。除EME 5–1,000 ng /贴片外,测定为线性1–1,000 ng /贴片。日内,日间和总不精确度分别为<10.1%CV,分析回收率87.2–107.7%,提取效率35.3–160.9%和过程效率25.5–91.7%。对EME(-63.3%)和EDDP(-60.4%)检测到离子抑制,对NBUP(42.6%)检测到离子抑制。氘代内标弥补了这些影响。未检测到残留物,并且所有分析物在22°C下保持24 h,在4°C下保持72 h并经过三个冷冻/解冻循环后保持稳定。该方法应用于阿片依赖的BUP维持孕妇的每周汗斑; BUP阳性的汗斑为75.0%,可卡因为93.8%,鸦片制剂为37.5%,美沙酮为6.3%,所有烟草生物标志物均为阳性。该方法可以快速,同时定量出汗斑中的14种药物和代谢物,并具有良好的选择性和灵敏度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号